Frequently Asked Questions:
- What is Arrowhead’s mission?
Arrowhead Research Corporation is a publicly traded nanotechnology holding company striving to bring new products to market via its subsidiaries in the healthcare, electronics, and clean energy industries.
Arrowhead was established in 2003 to address the opportunities presented by two intersecting forces: an explosion of basic nanotechnology research; and a market that we believed lacked an efficient mechanism to build and operate companies commercializing this science. We saw this as a big opportunity and sought to fill that role. Five years later, we have a set of market-leading subsidiaries with, we believe, near term monetization opportunities.
- Where is Arrowhead headquartered?
Arrowhead is headquartered in Pasadena, California.
- What is Arrowhead’s ticker symbol and on which exchange does it trade?
Arrowhead trades under ticker symbol ARWR on the NASDAQ Capital Market exchange.
- How many common shares are outstanding?
As of the close of May 15, 2009, the number of shares outstanding were 42,934,517.
- When does Arrowhead’s fiscal year end?
September 30
- Who is Arrowhead’s independent accountant?
Arrowhead's independent accountant is the firm of Rose, Snyder & Jacobs (Los Angeles, California).
- Who is Arrowhead’s transfer agent
and how do I contact them?
Computershare Trust Company
350 Indiana Street, Suite 800
Golden, CO 80401
Telephone: 1-800-962-4284
Fax: 1-303-262-0604
https://www-us.computershare.com - What is Arrowhead’s dividend policy?
Arrowhead has never declared or paid any dividends, nor does the company have any present plan to pay any cash dividends on common shares in the foreseeable future. Arrowhead currently intends to retain most, if not all, of its available funds and any future earnings to operate, increase its ownership positions in existing subsidiaries and acquire new subsidiaries.
- How can I purchase Arrowhead common shares? Does the company offer a direct stock purchase program?
Please contact a registered stockbroker to purchase shares of Arrowhead. The company does not offer a direct stock purchase program.
- How do I contact Investor Relations?
Please contact Arrowhead Investor Relations at:
Brandi Floberg
The Piacente Group (Investor Relations Counsel)
T: 212-481-2050
E: arrowres@tpg-ir.com